The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 13-1 Wednesday in favor of expanding the Pfizer/BioNTech Covid-19 vaccine booster recommendation to include people as young as 12.
The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted 13-1 Wednesday in favor of expanding the Pfizer/BioNTech Covid-19 vaccine booster recommendation to include people as young as 12.